Robert, Caroline,
Skin side effects targeted anti-EGFR and anti-BRAF therapies [electronic resource] / Caroline Robert. - London : Henry Stewart Talks, 2013. - 1 online resource (1 streaming video file (50 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Clinical presentation of skin adverse events occurring during anti-EGFR, anti-MEK and anti-BRAF agents -- Mechanisms underlying skin manifestation of targeted anticancer agents -- Management of the patients presenting with skin adverse events due to targeted anticancer agents.
Access restricted to subscribers.
Mode of access: World Wide Web.
3599 Henry Stewart Talks
Antineoplastic agents--Side effects.
Cancer--Chemotherapy--Complications.
Chemotherapy--Complications.
Antineoplastic Agents--adverse effects.
Antineoplastic Agents--therapeutic use.
Neoplasms--complications.
Neoplasms--drug therapy.
Skin side effects targeted anti-EGFR and anti-BRAF therapies [electronic resource] / Caroline Robert. - London : Henry Stewart Talks, 2013. - 1 online resource (1 streaming video file (50 min.) : color, sound). - The biomedical & life sciences collection, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Clinical presentation of skin adverse events occurring during anti-EGFR, anti-MEK and anti-BRAF agents -- Mechanisms underlying skin manifestation of targeted anticancer agents -- Management of the patients presenting with skin adverse events due to targeted anticancer agents.
Access restricted to subscribers.
Mode of access: World Wide Web.
3599 Henry Stewart Talks
Antineoplastic agents--Side effects.
Cancer--Chemotherapy--Complications.
Chemotherapy--Complications.
Antineoplastic Agents--adverse effects.
Antineoplastic Agents--therapeutic use.
Neoplasms--complications.
Neoplasms--drug therapy.